Comparison and modulation of angiogenic responses by FGFs, VEGF and SCF in murine and human fibrosarcomas

Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology

Volumn 132, Issue 1, 2002, Pages 17-25

  Ding, Ivan ^a   Liu, Weimin ^a   Sun, Jianzhong ^a   Fenton, Bruce ^a   Okunieff, Paul ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Angiogenesis; Blood vessels; Fibroblast growth factor; Fibrosarcoma; Hypoxic marker; Oxygenation; Perfusion; Stem cell growth factor; Vascular endothelial growth factor; Vasculature

Indexed keywords

ANGIOPOIETIN; ANTIGEN; ENDOGLIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 11; FIBROBLAST GROWTH FACTOR 13; FIBROBLAST GROWTH FACTOR 14; FIBROBLAST GROWTH FACTOR 2; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA; STEM CELL FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; FIBROSARCOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LIPOSARCOMA; MOUSE; NONHUMAN; NUDE MOUSE; OXYGENATION; PERFUSION; RIBONUCLEASE PROTECTION ASSAY; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; TUMOR CELL LINE; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME; ANIMAL; ARTICLE; C3H MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; COMPARATIVE STUDY; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

MURINAE;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTORS; FIBROSARCOMA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MICE; MICE, INBRED C3H; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; STEM CELL FACTOR; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036010209     PISSN: 10956433     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-6433(01)00524-4     Document Type: Conference Paper

References (46)

1. Angiogenesis in squamous cell carcinoma in situ and microinvasive carcinoma of the uterine cervix
2. Tumoral angiogenesis: Physiopathology, prognostic value and therapeutic perspectives
3. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels and serum angiogenic activity in patients with breast carcinoma
4. Angiogenesis: Mechanistic insights, neovascular diseases and therapeutic prospects
5. Mechanisms and therapeutic implications of angiogenesis
6. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
7. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis
8. Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome
9. Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas and lymph node metastases
10. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma
11. The hemostatic system as a regulator of angiogenesis
12. Role of soluble mediators in angiogenesis
13. Molecular mechanisms of blood vessel formation
14. Therapeutic potentials of angiostatin in the treatment of cancer
15. A strategy to discover circulating angiogenesis inhibitors generated by human tumors
16. Mouse model of angiogenesis
17. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia
18. Enhancement of tumor perfusion and oxygenation by carbogen and nicotinamide during single- and multifraction irradiation
19. 2 saturation measurements
20. Angiogenesis: Initiation and control
21. Angiogenesis inhibitors generated by tumors
22. Switch to the angiogenic phenotype during tumorigenesis
23. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool
24. Clinical studies with angiogenesis inhibitors: Biological rationale and challenges for their evaluation
25. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
26. Assessment of angiogenesis in breast carcinoma: An important factor in prognosis?
27. Tumor development under angiogenic signaling: A dynamical theory of tumor growth, treatment response and postvascular dormancy
28. The effect of shark cartilage extracts on the growth and metastatic spread of the SCCVII carcinoma
29. The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors
30. Relationship between radiobiological hypoxia and direct estimates of tumour oxygenation in a mouse tumour model
31. Cellular heterogeneity. Explanation for changing of tumor phenotype and biologic behavior in soft tissue sarcomas
32. Morphology and molecular biology of malignant soft tissue sarcomas
33. The prognostic significance of inflammatory cells in malignant human soft tissue tumors. Malignancy grading
34. Size dependent changes in tumor phosphate metabolism after radiation therapy as detected by 31 P NMR spectroscopy
35. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts
36. The influence of glucocorticoids on the growth of a human leiomyosarcoma cell line SK-LMS-1
37. Angiostatin induces and sustains dormancy of human primary tumors in mice
38. Tumor size dependent changes in a murine fibrosarcoma: Use of in vivo 31P NMR for non-invasive evaluation of tumor metabolic status
39. Neovascularity and clinical outcome in high-grade extremity soft tissue sarcomas
40. The effect of 1,25-dihydroxyvitamin D3 on the growth of soft-tissue sarcoma cells as mediated by the vitamin D receptor
41. Different patterns of angiogenesis in sarcomas and carcinomas
42. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors
43. Intratumor microvessel density as a prognostic factor in cancer
44. Angiogenesis in breast cancer
45. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
46. Vasculogenesis, angiogenesis and growth factors: Ephrins enter the fray at the border